Edition:
United States

People: Novo Nordisk A/S (NOVOb.CO)

NOVOb.CO on Copenhagen Stock Exchange

354.85DKK
22 Aug 2019
Change (% chg)

-- (--)
Prev Close
kr.354.85
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,462,583
52-wk High
kr.356.50
52-wk Low
kr.265.15

Daniels, Brian 

Dr. Brian Daniels, M.D. has been Independent Director at Novo Nordisk A/S since March 18, 2016. He is Member of the Remuneration and Research & Development Committees. He is Venture Partner with 5AM Venture Management, LLC, the United States. He has experience in clinical development, medical affairs and corporate strategy across a broad range of therapeutics areas within the pharmaceutical industry, especially in the US. He holds MD (1987) from Washington University, St. Louis, US, Bachelor of Science in Life Sciences (1981) and MA in Metabolism and Nutritional Biochemistry (1981), both from Massachusetts Institute of Technology, Cambridge, US.

Basic Compensation

Total Annual Compensation, DKK 1,400,000
Restricted Stock Awards, DKK --
Long-Term Incentive Plans, DKK --
All Other, DKK --
Fiscal Year Total, DKK 1,400,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --